MOTS-c, a peptide derived from mitochondria, offers a variety of health benefits. It helps maintain a balanced metabolism and has been linked to a longer lifespan. Additionally, MOTS-c has shown potential to improve exercise performance, reduce obesity, combat insulin resistance, and address various disease pathways, including osteoporosis. These diverse positive effects make MOTS-c an exciting area of research with implications for overall well-being.
Description
The term MOTS-c stands for "Mitochondrial Open Reading Frame of the 12S rRNA type c." It refers to a short peptide derived from the mitochondrial genome.
Mitochondria are organelles found in most eukaryotic cells and play a crucial role in energy production through cellular respiration. The mitochondrial genome is separate from the nuclear genome and encodes several essential proteins involved in mitochondrial function.
MOTS-c is a recently discovered peptide encoded within the mitochondria that has drawn scientific interest due to its potential regulatory roles in metabolism and aging. It is derived from the 12S rRNA gene (ribosomal RNA), part of the mitochondrial DNA.
Mots-C | Peptide
Freedom Research
MOTS-c is typically administered through subcutaneous injections, with the recommended dosage ranging from 10 to 20 mg per week. It is often injected 2-3 times per week, depending on individual goals. MOTS-c has been studied for its potential to improve metabolism, increase exercise performance, and combat obesity. It is commonly used in cycles of 4-6 weeks. Always consult a healthcare provider before starting to ensure proper dosage and usage.